Continuous Bioprocessing Market
- 2026 年市場規模
- USD 512.4 Mn
- 2033 年預估規模
- USD 1,991.3 Mn
- 年複合成長率 CAGR
- 21.4%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
完整報告名稱與涵蓋範圍
Continuous Bioprocessing Market, By Product (Continuous Bioreactors, Continuous Chromatography Systems, Continuous Filtration Systems, Continuous Cell Culture Systems, Continuous Media and Buffer Preparation Systems, Continuous Virus Inactivation Systems, Continuous Downstream Processing Systems, Others), By Process (Upstream Processing, Downstream Processing), By Scale of Operation (Small-Scale, Medium-Scale, Large-Scale), By Application (Monoclonal Antibodies, Recombinant Proteins, Vaccines, Cell and Gene Therapies, Blood and Plasma Products, Others), By End User (Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs) / Contract Development and Manufacturing Organizations (CDMOs), Academic and Research Institutes, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
The global continuous bioprocessing market is estimated to be valued at USD 512.4 Mn in 2026 and is expected to reach USD 1,991.3 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 21.4% from 2026 to 2033. The global continuous bioprocessing market is an evolution of the traditional batch manufacturing of biopharmaceuticals to the continuous, integrated and efficient production of biopharmaceuticals. The global continuous bioprocessing market is characterized by the use of technologies such as perfusion bioreactors, continuous chromatography and inline monitoring to manufacture biologicals such as monoclonal antibodies, vaccines, recombinant proteins and cell and gene therapies, while enhancing the process consistency, product quality, manufacturing footprint and operational efficiency.
The increasing demand for biologics and the biopharmaceutical companies’ focus on improving the economics of production and shortening the time-to-market are also driving the market adoption. Quality by Design (QbD) and Process Analytical Technology (PAT) regulatory initiatives, along with advances in automation and digital integration are also helping to accelerate the move toward continuous manufacturing as a significant part of next generation biopharmaceutical production.
Market Dynamics
The global continuous bioprocessing market is driven by the increasing demand for biologics such as monoclonal antibodies, biosimilars, vaccines and cell and gene therapies as manufacturers require higher productivity, lower cost of goods, smaller facility footprints and better process consistency. Regulatory support along with integration of Process Analytical Technology (PAT), artificial intelligence, machine learning and real-time release testing is further fueling adoption across biopharmaceutical manufacturers.
However, a number of constraints are present in the market, such as high capital requirements for migrating from batch-based infrastructure, complexity of process validation, regulatory uncertainty, and limited pool of skilled professionals. Nevertheless, significant opportunities exist in biosimilars, especially in Asia Pacific and Latin America, and presents considerable opportunities, as does individualized medicine, modular manufacturing and strategic alliances between technology providers, CDMOs and biopharmaceutical companies.
Key Features of the Study
• This report provides in-depth analysis of the global continuous bioprocessing market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global continuous bioprocessing market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Danaher Corporation, Sartorius AG, Thermo Fisher Scientific Inc., Merck KGaA, Repligen Corporation, Eppendorf SE, Getinge AB, 3M Company, Lonza Group Ltd., and Asahi Kasei Corporation
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global continuous bioprocessing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global continuous bioprocessing market
Market Segmentation
• Product Insights (Revenue, USD Mn, 2021 - 2033)
o Continuous Bioreactors
o Continuous Chromatography Systems
o Continuous Filtration Systems
o Continuous Cell Culture Systems
o Continuous Media and Buffer Preparation Systems
o Continuous Virus Inactivation Systems
o Continuous Downstream Processing Systems
o Others
• Process Insights (Revenue, USD Mn, 2021 - 2033)
o Upstream Processing
o Downstream Processing
• Scale of Operation Insights (Revenue, USD Mn, 2021 - 2033)
o Small-Scale
o Medium-Scale
o Large-Scale
• Application Insights (Revenue, USD Mn, 2021 - 2033)
o Monoclonal Antibodies
o Recombinant Proteins
o Vaccines
o Cell and Gene Therapies
o Blood and Plasma Products
o Others
• End User Insights (Revenue, USD Mn, 2021 - 2033)
o Biopharmaceutical Companies
o Contract Manufacturing Organizations (CMOs) / Contract Development and Manufacturing Organizations (CDMOs)
o Academic and Research Institutes
o Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Danaher Corporation
o Sartorius AG
o Thermo Fisher Scientific Inc.
o Merck KGaA
o Repligen Corporation
o Eppendorf SE
o Getinge AB
o 3M Company
o Lonza Group Ltd.
o Asahi Kasei Corporation
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Continuous Bioprocessing Market, By Product
Global Continuous Bioprocessing Market, By Process
Global Continuous Bioprocessing Market, By Scale of Operation
Global Continuous Bioprocessing Market, By Application
Global Continuous Bioprocessing Market, By End User
Global Continuous Bioprocessing Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Industry Trends
4. Global Continuous Bioprocessing Market, By Product, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Continuous Bioreactors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Continuous Chromatography Systems
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Continuous Filtration Systems
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Continuous Cell Culture Systems
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Continuous Media and Buffer Preparation Systems
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Continuous Virus Inactivation Systems
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Continuous Downstream Processing Systems
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Continuous Bioprocessing Market, By Process, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Upstream Processing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Downstream Processing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Continuous Bioprocessing Market, By Scale of Operation, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Small-Scale
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Medium-Scale
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Large-Scale
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Continuous Bioprocessing Market, By Application, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Monoclonal Antibodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Recombinant Proteins
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Cell and Gene Therapies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Blood and Plasma Products
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Continuous Bioprocessing Market, By End User, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Biopharmaceutical Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Contract Manufacturing Organizations (CMOs) / Contract Development and Manufacturing Organizations (CDMOs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Academic and Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Continuous Bioprocessing Market, By Region, 2021 - 2033, Value (USD Mn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Process, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Scale of Operation, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Process, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Scale of Operation, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Process, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Scale of Operation, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Process, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Scale of Operation, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Process, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Scale of Operation, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Process, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Scale of Operation, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
o South Africa
o North Africa
o Central Africa
10. Competitive Landscape
o Danaher Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Sartorius AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Thermo Fisher Scientific Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Merck KGaA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Repligen Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Eppendorf SE
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Getinge AB
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o 3M Company
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Lonza Group Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Asahi Kasei Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
11. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
12. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on ‘Continuous Bioprocessing Market' - Global forecast to 2033
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們